Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Response to allogeneic hematopoietic stem cell transplant Response to allogeneic hematopoietic stem cell transplant,response to allogeneic hematopoietic stem cell transplant
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- healthy volunteers
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- hematopoietic stem cell transplant recipients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- patients undergoing T cell repleted allogeneic hematopoietic stem cell transplantation
- Group 0 sample size Number of subjects in the control (unexposed) group
- 18
- Group 1 sample size Number of subjects in the case (exposed) group
- 50
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Richness Number of species
- decreased
Signature 1
Source: Text, Figure 1
Description: Clinical and Microbime Predictors of Acute GastroIntestinal Graft-vs- Host Disease
Abundance in Group 1: increased abundance in hematopoietic stem cell transplant recipients
NCBI | Quality Control | Links |
---|---|---|
Enterococcus |
Revision editor(s): WikiWorks
Signature 2
Source: Text, Figure 1
Description: Clinical and Microbime Predictors of Acute GastroIntestinal Graft-vs- Host Disease
Abundance in Group 1: decreased abundance in hematopoietic stem cell transplant recipients
NCBI | Quality Control | Links |
---|---|---|
Pseudobutyrivibrio | ||
Subdoligranulum |
Revision editor(s): WikiWorks
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- low fecal butyrate levels
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- high fecal butyrate levels
- Group 0 sample size Number of subjects in the control (unexposed) group
- 50
Lab analysis
Statistical Analysis
- Statistical test
- LEfSe
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 4
Signature 1
Source: Text, Figure 3, Supplemental figure 2
Description: Differences in fecal metabolites among hemapoietic stem cell transplant (HSCT) recipients at baseline
Abundance in Group 1: increased abundance in high fecal butyrate levels
Revision editor(s): WikiWorks
Signature 2
Source: Text, Figure 3, Supplemental figure 2
Description: Differences in fecal metabolites among hemapoietic stem cell transplant (HSCT) recipients at baseline
Abundance in Group 1: decreased abundance in high fecal butyrate levels
NCBI | Quality Control | Links |
---|---|---|
Lactobacillus | ||
Lactobacillaceae | ||
Enterococcus | ||
Enterococcaceae | ||
Lactobacillales | ||
Bacilli |
Revision editor(s): WikiWorks